New MS drug enters human testing: first look at safety and brain penetration
Disease control
Recruiting now
This early-stage study is testing a new experimental drug called VT7208 for multiple sclerosis (MS). First, researchers will check the drug's safety and how the body processes it in healthy volunteers. Then, a small group of adults with MS will receive the drug to see if it's saf…
Phase: PHASE1, PHASE2 • Sponsor: Vidya Therapeutics Inc • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC